1436175
Last Update Posted: 2021-06-14
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
1570 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
This study is an optional continuation of previous short-term adult major depressive disorder (MDD) augmentation studies. Patients may only take part in this long-term, open-label research study if they completed a previous double-blind MDD augmentation study using SPD489.
Eligibility
Relevant conditions:
Major Depressive Disorder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov